Loading data
MDAINasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 19.65 m USD | 29.58 m USD | 18.06 m USD | 25.37 m USD | — |
| Cost of revenue | 10.73 m USD | 16.31 m USD | 10.18 m USD | 14.5 m USD | — |
| Gross profit | 8.93 m USD | 13.27 m USD | 7.88 m USD | 10.84 m USD | — |
| Research and development expense | — | — | 15.1 m USD | 16.5 m USD | — |
| Operating profit | -8.6 m USD | -6.58 m USD | -12.98 m USD | -2.65 m USD | -3.42 m USD |
| Profit before tax | -7.56 m USD | -15.04 m USD | -20.84 m USD | -2.81 m USD | -2.15 m USD |
| Income tax expense | 11 k USD | 114 k USD | 11 k USD | 106 k USD | 0 USD |
| Net income (reported basis) | -7.57 m USD | -15.16 m USD | -20.85 m USD | -2.91 m USD | -2.15 m USD |
| Basic earnings per share | -0.29 USD/share | -0.85 USD/share | -1.48 USD/share | -0.22 USD/share | — |
| Diluted earnings per share | -0.29 USD/share | -0.85 USD/share | -1.48 USD/share | -0.22 USD/share | — |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.